Treace Medical Concepts (TMCI) Competitors $6.09 +0.07 (+1.16%) Closing price 04:00 PM EasternExtended Trading$6.10 +0.02 (+0.25%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. TNDM, SSII, CDRE, AORT, LQDA, FNA, ESTA, PLSE, BLFS, and MDXGShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Tandem Diabetes Care (TNDM), SS Innovations International (SSII), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), Paragon 28 (FNA), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors Tandem Diabetes Care SS Innovations International Cadre Artivion Liquidia Technologies Paragon 28 Establishment Labs Pulse Biosciences BioLife Solutions MiMedx Group Treace Medical Concepts (NASDAQ:TMCI) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk. Is TMCI or TNDM more profitable? Tandem Diabetes Care has a net margin of -18.71% compared to Treace Medical Concepts' net margin of -25.14%. Treace Medical Concepts' return on equity of -48.69% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-25.14% -48.69% -24.59% Tandem Diabetes Care -18.71%-57.33%-13.48% Do analysts recommend TMCI or TNDM? Treace Medical Concepts currently has a consensus target price of $10.16, indicating a potential upside of 66.78%. Tandem Diabetes Care has a consensus target price of $33.43, indicating a potential upside of 95.72%. Given Tandem Diabetes Care's stronger consensus rating and higher possible upside, analysts clearly believe Tandem Diabetes Care is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Tandem Diabetes Care 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more volatility & risk, TMCI or TNDM? Treace Medical Concepts has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Which has stronger valuation & earnings, TMCI or TNDM? Treace Medical Concepts has higher earnings, but lower revenue than Tandem Diabetes Care. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.83-$55.74M-$0.85-7.16Tandem Diabetes Care$940.20M1.21-$96.03M-$2.78-6.14 Does the media favor TMCI or TNDM? In the previous week, Tandem Diabetes Care had 8 more articles in the media than Treace Medical Concepts. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.86 beat Tandem Diabetes Care's score of 1.19 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tandem Diabetes Care 3 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in TMCI or TNDM? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryTandem Diabetes Care beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$378.60M$6.89B$5.54B$8.87BDividend YieldN/A1.16%5.39%4.10%P/E Ratio-7.1626.5426.1419.88Price / Sales1.8395.96414.67113.66Price / CashN/A21.0136.1356.90Price / Book3.364.718.055.38Net Income-$55.74M$173.18M$3.15B$248.50M7 Day Performance2.01%1.45%1.85%2.97%1 Month Performance6.10%0.27%4.81%6.02%1 Year Performance-8.14%29.02%34.86%20.39% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.5891 of 5 stars$6.09+1.2%$10.16+66.8%-7.2%$378.60M$209.36M-7.16250TNDMTandem Diabetes Care4.2138 of 5 stars$20.22flat$33.43+65.3%-56.3%$1.35B$940.20M-7.272,650Positive NewsSSIISS Innovations InternationalN/A$5.65-18.4%N/AN/A$1.34B$22.13M0.004Gap DownCDRECadre3.6765 of 5 stars$32.76-0.3%$37.50+14.5%-3.9%$1.34B$567.56M34.482,284AORTArtivion2.6265 of 5 stars$30.84+1.9%$32.00+3.8%+20.7%$1.29B$388.54M-61.671,600Positive NewsLQDALiquidia Technologies3.3726 of 5 stars$13.26+0.7%$26.89+102.8%-0.3%$1.13B$14M-8.3950Positive NewsFNAParagon 280.4962 of 5 stars$13.11+0.1%$12.75-2.7%+99.5%$1.10B$256.18M-17.71343,000High Trading VolumeESTAEstablishment Labs1.2754 of 5 stars$36.58-3.3%$52.40+43.2%+0.1%$1.09B$170.24M-11.801,018PLSEPulse Biosciences1.3697 of 5 stars$15.49+1.2%N/A+37.0%$1.03B$700K0.00140BLFSBioLife Solutions3.0716 of 5 stars$21.36+0.7%$31.17+45.9%+4.2%$1.01B$82.25M-73.65440Positive NewsMDXGMiMedx Group3.7419 of 5 stars$5.94+2.2%$12.50+110.4%-7.2%$858.15M$352.38M22.00870 Related Companies and Tools Related Companies Tandem Diabetes Care Alternatives SS Innovations International Alternatives Cadre Alternatives Artivion Alternatives Liquidia Technologies Alternatives Paragon 28 Alternatives Establishment Labs Alternatives Pulse Biosciences Alternatives BioLife Solutions Alternatives MiMedx Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
